DRGEM Corporation (263690) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.051x

Based on the latest financial reports, DRGEM Corporation (263690) has a cash flow conversion efficiency ratio of 0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.77 Billion ≈ $3.23 Million USD) by net assets (₩94.36 Billion ≈ $63.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DRGEM Corporation defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

DRGEM Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how DRGEM Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

DRGEM Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DRGEM Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lantern Pharma Inc NASDAQ:LTRN	-0.477x
Brand Group (M.G) Ltd TA:BRND	0.030x
Swiss Properties Invest A/S CO:SWISS	0.017x
Tevogen Bio Holdings Inc. NASDAQ:TVGN	0.278x
Kyung Chang Industrial Co. Ltd KQ:024910	0.012x
LOOP INDUSTRIES DL-001 F:3L9	0.241x
BG Staffing Inc NYSE:BGSF	0.042x
The Beachbody Company, Inc. NASDAQ:BODI	-0.038x

Annual Cash Flow Conversion Efficiency for DRGEM Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of DRGEM Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 263690 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩92.11 Billion ≈ $62.42 Million	₩11.61 Billion ≈ $7.87 Million	0.126x	+197.19%
2024-12-31	₩86.65 Billion ≈ $58.72 Million	₩3.68 Billion ≈ $2.49 Million	0.042x	-77.56%
2023-12-31	₩79.32 Billion ≈ $53.75 Million	₩14.99 Billion ≈ $10.16 Million	0.189x	+89.35%
2022-12-31	₩73.63 Billion ≈ $49.90 Million	₩7.35 Billion ≈ $4.98 Million	0.100x	-41.37%
2021-12-31	₩61.01 Billion ≈ $41.34 Million	₩10.39 Billion ≈ $7.04 Million	0.170x	-11.38%
2020-12-31	₩52.53 Billion ≈ $35.60 Million	₩10.09 Billion ≈ $6.84 Million	0.192x	+109.64%
2019-12-31	₩32.52 Billion ≈ $22.04 Million	₩2.98 Billion ≈ $2.02 Million	0.092x	-12.35%
2018-12-31	₩28.68 Billion ≈ $19.43 Million	₩3.00 Billion ≈ $2.03 Million	0.105x	-31.41%
2017-12-31	₩15.65 Billion ≈ $10.61 Million	₩2.39 Billion ≈ $1.62 Million	0.152x	-67.90%
2016-12-31	₩9.54 Billion ≈ $6.46 Million	₩4.53 Billion ≈ $3.07 Million	0.475x	+196.20%
2015-12-31	₩7.93 Billion ≈ $5.37 Million	₩1.27 Billion ≈ $861.60K	0.160x	--

About DRGEM Corporation

KQ:263690 Korea Medical Devices

Market Cap

$39.58 Million

₩58.40 Billion KRW

Market Cap Rank

#22799 Global

#1486 in Korea

Share Price

₩5360.00

Change (1 day)

+0.19%

52-Week Range

₩4890.00 - ₩6510.00

All Time High

₩21390.25